| Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study. | |
| | |
MedLine Citation:
|
PMID: 19773667 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Although chronic infection with the hepatitis C virus (HCV) may lead to the development of cirrhosis and its complications, little data are available on progression to the decompensated stage in a hetereogeneous population. Our aims were to characterize the burden of HCV-related decompensated cirrhosis on the national health care system in Scotland in terms of hospital admissions and length of stay, and to estimate the associations between epidemiological variables and time to the first hospital admission/death with mention of decompensated cirrhosis. METHODS: We carried out a record-linkage study of 20 969 individuals diagnosed with hepatitis C through laboratory testing between 1991 and 30 June 2006, whose records were linked to the Scottish Morbidity Records hospital discharge database and to national HIV databases. RESULTS: Nine hundred and ninety-five individuals were admitted to hospital and 63 individuals died with first-time mention of decompensated cirrhosis during follow-up (median 5.2 years). The number of new cases increased over the period 1996-2005, with an average annual change of 11% [95% confidence interval (CI): 8-13]. The relative risk of developing decompensated cirrhosis was greater for men (hazard ratio = 1.4, 95% CI: 1.1-1.7), for those coinfected with HIV (hazard ratio = 2.1, 95% CI: 1.4-3.3), for those with a prior alcohol-related admission, fitted as a time-dependent covariate (hazard ratio = 5.5, 95% CI: 4.6-6.6) and for those aged 30 years or older (30-39 years: hazard ratio = 3.7, 95% CI: 2.4-5.8; 40-49 years: hazard ratio = 10.0, 95% CI: 6.5-15.6; 50-59 years: hazard ratio = 20.6, 95% CI: 12.9-32.9, 60 years or older: hazard ratio = 37.4, 95% CI: 22.8-61.3). CONCLUSION: The burden from HCV-infected individuals developing cirrhotic complications is increasing because of the advancing age of this population. On account of the synergistic effect of HCV and excessive alcohol consumption on the development of liver disease, it is essential that policy-makers address alcohol intake when allocating resources for the management of HCV infection. |
| | |
Authors:
|
Scott A McDonald; Sharon J Hutchinson; Sheila M Bird; Peter R Mills; Chris Robertson; John F Dillon; Toni Williams; David J Goldberg |
Related Documents
:
|
4193097 - Immunological and histological studies in primary biliary cirrhosis. 18662837 - Clinical and pathologic risk factors for atherosclerosis in cirrhosis: a comparison bet... 3884477 - Serum beta 2-microglobulin levels in primary biliary cirrhosis. 1505897 - Synthesis of eicosanoids by circulating mononuclears in healthy people and in patients ... 9382157 - Localization of hepatocyte growth factor and tubulointerstitial lesions in iga nephropa... 21063477 - New antiviral therapies for chronic hepatitis c. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: European journal of gastroenterology & hepatology Volume: 22 ISSN: 1473-5687 ISO Abbreviation: Eur J Gastroenterol Hepatol Publication Date: 2010 Jan |
Date Detail:
|
Created Date: 2009-12-04 Completed Date: 2011-01-19 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9000874 Medline TA: Eur J Gastroenterol Hepatol Country: England |
Other Details:
|
Languages: eng Pagination: 49-57 Citation Subset: IM |
Affiliation:
|
Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, UK. smcdonald4@nhs.net |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Alcoholism / complications, epidemiology Epidemiologic Methods Female HIV Infections / complications, epidemiology Hepatitis C, Chronic / complications*, epidemiology Hospitalization / statistics & numerical data* Humans Liver Cirrhosis / epidemiology, etiology, virology* Male Middle Aged Scotland / epidemiology Substance Abuse, Intravenous / complications, epidemiology |
| Grant Support | |
ID/Acronym/Agency:
|
//Medical Research Council |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cost-effectiveness of the artificial liver support system MARS in patients with acute-on-chronic liv...
Next Document: Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: A HuGE review and met...